key: cord-0956448-wrjubbwd
authors: Haile, S.; Nikiforuk, A. M.; Pandoh, P. K.; Twa, D. D. W.; Smailus, D. E.; Nguyen, J.; Pleasance, S.; Wong, A.; Zhao, Y.; Eisler, D.; Moksa, M.; Cao, Q.; Wong, M.; Su, E.; Krzywinski, M.; Nelson, J. M. T.; Mungall, A. J.; Tsang, F.; Prentice, L. M.; Jassem, A.; Manges, A. R.; Jones, S. J. M.; Coope, R. J.; Prystajecky, N.; Marra, M. A.; Krajden, M.; Hirst, M.
title: Optimization of magnetic bead-based nucleic acid extraction for SARS-CoV-2 testing using readily available reagents
date: 2021-03-12
journal: nan
DOI: 10.1101/2021.03.09.21251364
sha: 9dcc52dedeefe705cf04b46a4d5a883ff12d6434
doc_id: 956448
cord_uid: wrjubbwd

The COVID-19 pandemic has highlighted the need for generic reagents and flexible systems in diagnostic testing. Magnetic bead-based nucleic acid extraction protocols using 96-well plates on open liquid handlers are readily amenable to meet this need. Here, one such approach is rigorously optimized to minimize cross-well contamination while maintaining sensitivity.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.09.21251364 doi: medRxiv preprint

The COVID-19 pandemic has placed unprecedented strain on instrument and consumable supply chains for SARS-CoV-2 nucleic acid (NA) testing (1). NA protocols involve lysis and purification of NAs on columns or magnetic beads. Bead-based protocols are amenable to automated workflows and are widely available, rendering them attractive alternatives to proprietary commercial offerings (2) . Recent reports have suggested that generic bead-based protocols can be successfully deployed on generic open-deck liquid handling instruments (3) (4) (5) ; yet lack rigorous measures of specificity and sensitivity that are required for clinical deployment.

We sought to establish an automated protocol to support extraction-based SARS-CoV-2 Widespread adoption of this commercial workflow during the pandemic has driven ongoing shortages in reagents and motivated this study. This reagent shortage extended to many other manufacturers of automated NA extraction systems.

Magnetic bead-based NA purification workflows deployed on open liquid handling platforms support various chemistries and plastic-ware configurations, providing critical flexibility in the face of global supply chain instabilities. Here, we provide a benchmarked standard operating procedure (SOP; Appendix 1 and 2) that employs a guanidine-thiocyanate . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.09.21251364 doi: medRxiv preprint containing lysis buffer followed by NA purification using magnetic beads and deployed on a Hamilton NIMBUS liquid handler (Appendix-3A). The SOP is designed to accept specimens aliquoted into a plate from a variety of commercial transport mediums (Copan UTM, Hologic STM, Roche cobas® PCR Media, YOCON UTM) or common laboratory buffers. Cultured Influenza A virus (Flu-A) spiked into transport medium was used for initial comparisons between the NIMBUS and MagMax protocols. Following extraction, Flu-A RNA recovery was measured using a TaqMan qRT-PCR assay, developed by BCCDC, that detects Flu-A, Flu-B and RSV. The PCR cycle threshold (Ct) values obtained from the NIMBUS protocol were lower than those obtained from the MagMax protocol across dilutions when Copan UTM was used as virus diluent by an average of 1.13 Ct (p=0.0039; Appendix 3B).

When Hologic STM was used, the opposite was observed, with higher values from the NIMBUS protocol compared to those from the MagMax protocol by an average of 0.22 Ct (p=0.0301; Appendix 3C). These results suggest that the NIMBUS protocol provides comparable sensitivity to the MagMax protocol.

To measure specificity of our protocol we deployed a "checkerboard" input plate where Copan UTM containing Flu-A was alternated with Copan UTM alone. This test revealed a ~85% specificity; carryover into blank wells was judged to be an aggregate effect of the manual processes performed in the biosafety cabinet (BSC) and automated liquid handling. To decouple these sources of contamination, we utilized synthetic DNA (g-block) controls and matched primers and probe sets. A master checkerboard plate was first generated by aliquoting an amount of g-block DNA sufficient for an extraction-free control plate and three extraction test plates. Using a dedicated NIMBUS, the master plate was aliquoted into a control plate containing elution buffer only and into a deep-well plate that was pre-loaded with a mixture of Copan UTM, . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.09.21251364 doi: medRxiv preprint RLT Plus, beads, and isopropanol to mimic the extraction chemical milieu (extraction plates), respectively. The samples from two of the extraction plates were then purified using a second NIMBUS and those from the third extraction plate were purified on a third NIMBUS. As shown in Figure 1 , all the 40 blank wells in the control plate were determined to be negative via the qPCR assay (i.e. undetermined Ct values) (100% specificity). In contrast, the three extraction plates displayed 17, 13 and 12 false positive wells, representing 65% specificity.

To improve specificity, we switched from 1.2mL to 2.2 mL deep-well plates, reduced tip mixing steps and number of washes and optimized pipetting techniques to eliminate residual droplets. We wrote new code to eliminate extraneous vertical movement of the robot head between aspirate and dispense steps and to reduce the robot gantry's lateral speed to prevent dislodging of any residual droplets adhering to tips. The details of all the changes are described in Appendices 4 and 5.

We tested the aggregate effects of all the changes in the optimized NIMBUS protocol Having established comparable sensitivity of our optimized NIMBUS protocol to that of the initial version of the NIMBUS and the MagMax protocols, we next tested its specificity. We performed three independent experiments using g-block checkerboards, each including two extraction-free control plates and two extraction test plates (total of 240 positive wells and negative wells). None of the blank wells had detectable NA and all wells with g-block DNA yielded expected Ct values indicating 100% sensitivity and specificity. A Flu-A checkerboard was performed and again achieved 100% sensitivity and specificity (Figure 2C) .

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. with Ct values that ranged from 13.8 to 36.8 (Figure 2D) , there was a strong correlation between the two protocols (R 2 >0.996) (Appendix-6). There were slightly higher Ct values (by a median of 0.43 Ct for RDRP and 0.50 Ct for E-gene) from the NIMBUS protocol (p=1.89E-08 and p=9.94-E08, respectively). Taken together, our analysis indicates that the optimized NIMBUS protocol yields 100% specificity and sensitivity and comparable RNA yield, compared to the MagMax protocol used routinely at BCCDC PHL.

Generic nucleic-acid purification protocols provide an alternative reagent stream for SARS-CoV-2 testing but require optimization and customization to meet clinical sensitivity and specificity requirements. Here we provide a benchmarked SOP for one such protocol deployed on a Hamilton NIMBUS platform. and E-gene, respectively (paired, two-tailed t-test).

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

Integrated DNA and RNA extraction using magnetic beads from viral pathogens causing acute respiratory infections

Overcoming the bottleneck to widespread testing: a rapid review of nucleic acid testing approaches for COVID-19 detection

SARS-CoV-2 RNA Extraction Using Magnetic Beads for Rapid Large-Scale Testing by RT-qPCR and RT-LAMP